Alkermes plc (NASDAQ:ALKS) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Alkermes' Third Quarter 2024 Financial Results Conference Call. My name is Maria and I'll be your operator for today's call.
Posts Tagged ‘NASDAQ:ALKS’
10 Most Undervalued Quality Stocks To Buy According To Analysts
Despite global uncertainties, the US economy is viewed as stronger than its international counterparts.
Alkermes plc (NASDAQ:ALKS) Q2 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Alkermes' Second Quarter 2024 Financial Results Conference Call. My name is Rob and I'll be your operator for today's call.
Alkermes plc (NASDAQ:ALKS) Q4 2023 Earnings Call Transcript
Alkermes plc misses on earnings expectations. Reported EPS is $0.22 EPS, expectations were $0.46.
5 Most Promising Psychedelic Stocks According to Hedge Funds
In this piece, we will take a look at the five most promising psychedelic stocks according to hedge funds.
12 Best Growth Stocks to Buy According to Billionaire Ray Dalio’s Bridgewater Associates
In this piece, we will take a look at the 12 best growth stocks to buy according to billionaire Ray Dalio's Bridgewater Associates.
Jim Simons Stock Portfolio: 12 Biggest Healthcare Stocks
In this piece, we will take a look at the 12 biggest healthcare stocks in Jim Simons' stock portfolio.
5 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
Below we present the list of 5 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Alkermes plc (NASDAQ:ALKS) Q3 2023 Earnings Call Transcript
Operator: Greetings. And welcome to the Alkermes Third Quarter 2023 Financial Results Conference Call. My name is Donna and I’ll be your operator for today’s call.
Alkermes plc (NASDAQ:ALKS) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Alkermes Second Quarter 2023 Earnings Financial Results Conference Call.
Alkermes plc (NASDAQ:ALKS) Q1 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Alkermes First Quarter 2023 Financial Results Conference Call. My name is Rob and I'll be your operator for today's call.
Alkermes plc (NASDAQ:ALKS) Q4 2022 Earnings Call Transcript
Operator: Greetings and welcome to the Alkermes Fourth Quarter 2022 Financial Results Conference Call. My name is Rob, and I will be your operator for today's call.
Was The Smart Money Right About Alkermes Plc (ALKS)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Are Selling Alkermes Plc (ALKS)
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
10 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors
In this article, we take a look at the 10 pharmaceutical stocks to buy according to Brandon Haley’s Holocene Advisors.
5 Stocks to Invest in According to Kenneth Squire’s 13D Management
In this article, we will discuss the 5 stocks to invest in according to Kenneth Squire's 13D Management.
Hedge Funds Have Never Been This Bullish On Alkermes Plc (ALKS)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
5 Best Mid-Cap Stocks For 2021
Alkermes plc (NASDAQ: ALKS) is a biopharmaceutical company with a focus on psychiatric and neurological disorders including schizophrenia as well as alcohol and opioid dependence...
5 Pharma Companies Making Treatment for Opioid Overdose
In this article, we discuss the 5 pharma companies making treatment for opioid overdose.
Is Alkermes Plc (ALKS) A Good Stock To Buy?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Is ALKS Stock A Buy or Sell?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Alkermes Plc (ALKS): Hedge Funds Taking Some Chips Off The Table
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
20 Most Drug Infested Cities in the U.S.
The 20 most drug infested cities in the US are a reminder that drugs are indeed a major problem in the US.
Did Hedge Funds Make The Right Call On Alkermes Plc (ALKS) ?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Should You Avoid Alkermes Plc (ALKS)?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Here is What Hedge Funds Think About Alkermes Plc (ALKS)
We hate to say this but, we told you so.
Hedge Fund Favorites vs. Alkermes Plc (ALKS) In 2019
2018's fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about...
Hedge Funds Are Warming Up To Alkermes Plc (ALKS)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Is Alkermes Plc (ALKS) Going To Burn These Hedge Funds ?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Here’s What Hedge Funds Think About Alkermes Plc (ALKS)
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Here’s What Hedge Funds Think About Alkermes Plc (ALKS)
Does Alkermes Plc (NASDAQ:ALKS) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company.
Do Hedge Funds Love Alkermes Plc (ALKS)?
Concerns over rising interest rates and expected further rate increases have hit several stocks hard since the end of the third quarter.
Market Movers Today: Alnylam Pharmaceuticals, Inc. (ALNY), Snap Inc (SNAP), Sellas Life Sciences Group Inc (SLS), Intel Corporation (INTC), and More
What happened: Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a precommercial pioneer of RNA-based therapies, continued a slide that began just ahead of the weekend.
5 Opioid Treatment Stocks
The five opioid treatment stocks are among several companies that have taken their own approach to the growing opioid addiction market in the US, which also happens to be the...
Netflix, Inc. (NFLX), General Electric Company (GE): Mott Capital Management’s Top Winners and Losers of 2017
Mott Capital Management is a thematic growth fund that was founded in 2014 by Michael J. Kramer. Mr.
10 Biggest Antidepressant Drug Companies In 2017
The 10 biggest antidepressant drug companies in 2017 are committed to providing the safest and most cost-effective solution for consumers suffering from mental diseases worldwide...
Here’s What Mott Capital Management Thinks About Netflix, Alkermes, Vodafone & More
Mott Capital Management was founded in 2014 by Michael J. Kramer.
Mott Capital Says Netflix (NFLX) At Forefront of Paradigm Shift, Talks Disney, Hain, NXPI Deal, More
Michael Kramer's Mott Capital just released its Q4 letter to investors, which discussed the fund's trying 2016 and some of its portfolio moves during the fourth quarter of last...
Alkermes Plc (ALKS): Are Hedge Funds Right About This Stock?
We at Insider Monkey have gone over 742 13F filings that hedge funds and prominent investors are required to file by the government.
Bristol Myers Squibb Co. (BMY), Alkermes Plc (ALKS) & More: How Opus Point’s Bet on Healthcare Sector Paid Off?
Opus Point Partners Management is a New York-based fund led by Michael S. Weiss and Lindsay A. Rosenwald.
AbbVie Inc (ABBV), Alkermes PLC (ALKS): Will Woodford Investment’s Long Positions Rule the Market Again in Q4?
Woodford Investment Management is a London-based hedge fund founded in 2016 by Neil Woodford.
Reynolds American, Inc. (RAI), MGP Ingredients Inc (MGPI), and More: Here’s What Analysts Had To Say About These Stocks in the Spotlight
Given that analysts can often affect short term sentiment, we at Insider Monkey have put together a list of recent Wall Street analyst commentary concerning five stocks, Reynolds...
Why Traders Are Buzzing About Qualcomm, NXP, Alkermes, Cerecor, and More
In this article, we'll examine the associated reasons why QUALCOMM, Inc.
A Look At Recro Pharma Inc (REPH) and Alkermes Plc (ALKS)’s Topline Triumph
Recro Pharma Inc (NASDAQ:REPH) is up more than 27% on Wednesday after announcing data from its lead acute pain trial.
Hedge Funds Regret Buying These Stocks in Q4
Hedge funds are able to charge their clients high fees because of their ability to deliver superior returns and outperform benchmarks.
Why These 5 Stocks Are Plummeting Today
The markets have finally managed to catch a break today, as all major stock indexes have registered gains of more than 1.3%.
Is Alkermes Plc (ALKS) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
Woodford Investment Management Has A Lot Riding On These 5 Stocks
Woodford Investment Management recently filed its Form 13F with the U.S. Securities and Exchange Commission (SEC) for the reporting period of September 30.
These Two Stocks Are in the Spotlights and Hedge Funds Suggest One of Them is a Buy
Alkermes Plc (NASDAQ:ALKS) and Apollo Education Group Inc (NASDAQ:APOL) are in the news after the FDA approved Alkermes Plc's ARISTADA for the treatment of schizophrenia while...
Top New Picks of Healthcare Fund Blue Jay Capital: Endo International plc (ENDP), Alkermes Plc (ALKS), Akorn Inc. (AKRX)
Healthcare-focused fund Blue Jay Capital Management, managed by Paul Sinclair, has disclosed its equity portfolio for the reporting period of March 31 in a 13F filed with the ...
